2006 Annual Meeting | Hot Topics in Multiple Sclerosis: Current Controversy and Consensus

Date Friday 04/07/06

Time 01:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Aaron E. Miller, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should acquire a better understanding of the existing controversies and gain information that will help to guide them in making their own therapeutic decisions for patients with central nervous system demyelinating disorders.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
01:15 PM - 01:20 PM		Introduction Aaron E. Miller, MD, FAAN
01:20 PM - 02:10 PM		Is Multiple Sclerosis One Disease or Many? Treatment Implications From Pathology Samuel Ludwin, MD
02:10 PM - 03:00 PM		Should All Patients With Multiple Sclerosis Be Treated With Disease–modifying Agents? John H. Noseworthy, MD, FAAN
03:00 PM - 03:15 PM		Break
03:15 PM - 04:05 PM		Antibodies to Disease–modifying Agents for Multiple Sclerosis: Considerations for Clinicians Reinhard Hohlfeld, MD
04:05 PM - 05:00 PM		Selective Adhesion Molecule Inhibitors: Will They Have a Role in the Treatment of Multiple Sclerosis? Aaron E. Miller, MD, FAAN

Faculty Disclosures
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Samuel Ludwin, MD	No disclosure on file
John H. Noseworthy, MD, FAAN	No disclosure on file
Reinhard Hohlfeld, MD	Dr. Hohlfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .

��ɫ��

��ɫ��